Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A randomized, double-blind, placebo-controlled, parallel-group study of cariprazine in schizophrenia
2011-002048-29Phase 3Completed
- Sponsor
- Forest Research Institute, Inc
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Cariprazine with Placebo (2 arms). Primary endpoint: Time to first relapse during the double-blind period. Started Nov 2011; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2011-002048-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002048-29.